Literature DB >> 15358310

Simultaneous determination of levofloxacin, gatifloxacin and moxifloxacin in serum by liquid chromatography with column switching.

Hoang Anh Nguyen1, Jean Grellet, Boubakar B Ba, Claudine Quentin, Marie-Claude Saux.   

Abstract

Liquid chromatography with a column-switching technique was developed for simultaneous direct quantification of levofloxacin, gatifloxacin and moxifloxacin in human serum. Serum samples were injected on a LiChroCART 4-4 pre-column (PC) filled with a LiChrospher 100 RP-18, 5 microm where fluoroquinolones (FQs) were purified and concentrated. The FQs were back-flushed from the PC and then separated on a Supelcosil ABZ+ Plus (150 mm x 4.6 mm i.d.) analytical column with a mobile phase containing 10 mM phosphate buffer (pH 2.5), acetonitrile (88:12, v/v) and 2mM tetrabutyl ammonium bromide. The effects of ion-pair reagents, buffer type, pH and acetonitrile concentrations in the mobile phase on the separation of the three FQs were investigated. Fluorescence detection provided sufficient sensitivity to achieve a quantification limit of 125 ng/ml for levofloxacin and moxifloxacin; 162.5 ng/ml for gatifloxacin with a 5 microl sample size. The on-line process of extraction avoids time-consuming treatment of the samples before injection and run time is shortened. The recovery, selectivity, linearity, precision and accuracy of the method are convenient for pharmacokinetic studies or routine assays.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358310     DOI: 10.1016/j.jchromb.2004.07.019

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  8 in total

1.  Development and validation of stability-indicating high performance liquid chromatography method to analyze gatifloxacin in bulk drug and pharmaceutical preparations.

Authors:  Ibrahim A Aljuffali; Mohd Abul Kalam; Yasmin Sultana; Ahamad Imran; Aws Alshamsan
Journal:  Saudi Pharm J       Date:  2014-06-28       Impact factor: 4.330

2.  Ultrasensitive study of gatifloxacin based on its enhancing effect on the cerium (IV)-sodium hyposulfite chemiluminescence reaction in a micellar medium.

Authors:  Mohammad Kamruzzaman; Al-Mahmnur Alam; Taslima Ferdous; Sang Hak Lee; Young Ho Kim; Sung Hong Kim
Journal:  J Fluoresc       Date:  2011-01-19       Impact factor: 2.217

3.  Activity of gatifloxacin in an in vitro pharmacokinetic-pharmacodynamic model against Staphylococcus aureus strains either susceptible to ciprofloxacin or exhibiting various levels and mechanisms of ciprofloxacin resistance.

Authors:  Boubakar B Ba; Corinne Arpin; Céline Vidaillac; Arnaud Chausse; Marie-Claude Saux; Claudine Quentin
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

4.  Simultaneous determination of moxifloxacin and cefixime by first and ratio first derivative ultraviolet spectrophotometry.

Authors:  Mahesh Attimarad; Bander E Al-Dhubiab; Ibrahim A Alhaider; Anroop B Nair; Sree Harsha N; Mueen Ahmed K
Journal:  Chem Cent J       Date:  2012-09-20       Impact factor: 4.215

Review 5.  Analytical Methods for Determining Third and Fourth Generation Fluoroquinolones: A Review.

Authors:  Andrzej Czyrski
Journal:  Chromatographia       Date:  2016-12-23       Impact factor: 2.044

6.  Improved HPLC method for the determination of moxifloxacin in application to a pharmacokinetics study in patients with infectious diseases.

Authors:  Nan Wang; Liqin Zhu; Xuequn Zhao; Wenjie Yang; He Sun
Journal:  ISRN Pharmacol       Date:  2013-05-26

7.  validated microbiological and HPLC methods for the determination of moxifloxacin in pharmaceutical preparations and human plasma.

Authors:  Ahmed A Abdelaziz; Tarek E Elbanna; Noha M Gamaleldeen
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

8.  Fiberoptic-Coupled Spectrofluorometer with Array Detection as a Process Analytical Chemistry Tool for Continuous Flow Monitoring of Fluoroquinolone Antibiotics.

Authors:  Nader Shokoufi; Maryam Vosough; Mona Rahimzadegan-Asl; Atefeh Abbasi-Ahd; Mahsa Khatibeghdami
Journal:  Int J Anal Chem       Date:  2020-02-07       Impact factor: 1.885

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.